See also this year's filing and all EDGAR filings for this company.
PDF Report 0001419600_2019_Flexion_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001419600, Flexion Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 285,042,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 10,710,000 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 36,617,000 |
| 5 | LiabilitiesNoncurrent | 4,177,000 |
| 6 | remainder_Liabilities | 144,879,000 |
| 7 | CostOfGoodsAndServicesSold | 7,336,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 333,149,835 |
| 9 | ResearchAndDevelopmentExpense | 53,723,890 |
| 10 | remainder_Expenses | 3,994 |
| 11 | remainder_Revenues | 133,368,999 |
| 12 | remainder_NetIncome | -15,773,881 |
| 13 | remainder_ComprehensiveNetIncome | -335,557 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 295,752,000 |
| 1 | Liabilities | 185,673,000 |
| 2 | Expenses | 394,213,719 |
| 3 | Revenues | 133,368,999 |
| 4 | StockholdersEquity | 110,079,000 |
| 5 | NetIncome | -276,618,601 |
| 6 | ComprehensiveNetIncome | -276,786,380 |
| 7 | BaseVar | 512,558,578 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.153 |
| 9 | EconomicCapitalRatio | 1.41 |
Edgar->Model Mapping
Feature Distribution
Change over Time
